290 related articles for article (PubMed ID: 12668365)
1. Paroxetine treatment of generalized anxiety disorder: a double-blind, placebo-controlled study.
Rickels K; Zaninelli R; McCafferty J; Bellew K; Iyengar M; Sheehan D
Am J Psychiatry; 2003 Apr; 160(4):749-56. PubMed ID: 12668365
[TBL] [Abstract][Full Text] [Related]
2. Paroxetine in the treatment of generalized anxiety disorder: results of a placebo-controlled, flexible-dosage trial.
Pollack MH; Zaninelli R; Goddard A; McCafferty JP; Bellew KM; Burnham DB; Iyengar MK
J Clin Psychiatry; 2001 May; 62(5):350-7. PubMed ID: 11411817
[TBL] [Abstract][Full Text] [Related]
3. A randomized, double-blind, fixed-dose comparison of paroxetine and placebo in the treatment of generalized social anxiety disorder.
Liebowitz MR; Stein MB; Tancer M; Carpenter D; Oakes R; Pitts CD
J Clin Psychiatry; 2002 Jan; 63(1):66-74. PubMed ID: 11838629
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of low doses of paroxetine controlled release in the treatment of major depressive disorder.
Trivedi MH; Pigotti TA; Perera P; Dillingham KE; Carfagno ML; Pitts CD
J Clin Psychiatry; 2004 Oct; 65(10):1356-64. PubMed ID: 15491239
[TBL] [Abstract][Full Text] [Related]
5. Venlafaxine extended release vs placebo and paroxetine in social anxiety disorder.
Liebowitz MR; Gelenberg AJ; Munjack D
Arch Gen Psychiatry; 2005 Feb; 62(2):190-8. PubMed ID: 15699296
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of sertraline in a 12-week trial for generalized anxiety disorder.
Allgulander C; Dahl AA; Austin C; Morris PL; Sogaard JA; Fayyad R; Kutcher SP; Clary CM
Am J Psychiatry; 2004 Sep; 161(9):1642-9. PubMed ID: 15337655
[TBL] [Abstract][Full Text] [Related]
7. Selective serotonin reuptake inhibitor treatment for generalized anxiety disorder: a double-blind, prospective comparison between paroxetine and sertraline.
Ball SG; Kuhn A; Wall D; Shekhar A; Goddard AW
J Clin Psychiatry; 2005 Jan; 66(1):94-9. PubMed ID: 15669894
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of paroxetine for the long-term treatment of generalized anxiety disorder.
Stocchi F; Nordera G; Jokinen RH; Lepola UM; Hewett K; Bryson H; Iyengar MK;
J Clin Psychiatry; 2003 Mar; 64(3):250-8. PubMed ID: 12716265
[TBL] [Abstract][Full Text] [Related]
9. A double-blind, multicenter, parallel-group study of paroxetine, desipramine, or placebo in breast cancer patients (stages I, II, III, and IV) with major depression.
Musselman DL; Somerset WI; Guo Y; Manatunga AK; Porter M; Penna S; Lewison B; Goodkin R; Lawson K; Lawson D; Evans DL; Nemeroff CB
J Clin Psychiatry; 2006 Feb; 67(2):288-96. PubMed ID: 16566626
[TBL] [Abstract][Full Text] [Related]
10. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
[TBL] [Abstract][Full Text] [Related]
11. A multicenter, randomized, double-blind, placebo-controlled trial of paroxetine in children and adolescents with social anxiety disorder.
Wagner KD; Berard R; Stein MB; Wetherhold E; Carpenter DJ; Perera P; Gee M; Davy K; Machin A
Arch Gen Psychiatry; 2004 Nov; 61(11):1153-62. PubMed ID: 15520363
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of extended-release venlafaxine in the treatment of generalized anxiety disorder in children and adolescents: two placebo-controlled trials.
Rynn MA; Riddle MA; Yeung PP; Kunz NR
Am J Psychiatry; 2007 Feb; 164(2):290-300. PubMed ID: 17267793
[TBL] [Abstract][Full Text] [Related]
13. Tiagabine for the treatment of generalized anxiety disorder: a randomized, open-label, clinical trial with paroxetine as a positive control.
Rosenthal M
J Clin Psychiatry; 2003 Oct; 64(10):1245-9. PubMed ID: 14658975
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of controlled-release paroxetine in the treatment of panic disorder.
Sheehan DV; Burnham DB; Iyengar MK; Perera P;
J Clin Psychiatry; 2005 Jan; 66(1):34-40. PubMed ID: 15669886
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of duloxetine in the treatment of generalized anxiety disorder: a flexible-dose, progressive-titration, placebo-controlled trial.
Rynn M; Russell J; Erickson J; Detke MJ; Ball S; Dinkel J; Rickels K; Raskin J
Depress Anxiety; 2008; 25(3):182-9. PubMed ID: 17311303
[TBL] [Abstract][Full Text] [Related]
16. Remission of generalized anxiety disorder: a review of the paroxetine clinical trials database.
Rickels K; Rynn M; Iyengar M; Duff D
J Clin Psychiatry; 2006 Jan; 67(1):41-7. PubMed ID: 16426087
[TBL] [Abstract][Full Text] [Related]
17. The efficacy of paroxetine and placebo in treating anxiety and depression: a meta-analysis of change on the Hamilton Rating Scales.
Sugarman MA; Loree AM; Baltes BB; Grekin ER; Kirsch I
PLoS One; 2014; 9(8):e106337. PubMed ID: 25162656
[TBL] [Abstract][Full Text] [Related]
18. Paroxetine in the treatment of chronic posttraumatic stress disorder: results of a placebo-controlled, flexible-dosage trial.
Tucker P; Zaninelli R; Yehuda R; Ruggiero L; Dillingham K; Pitts CD
J Clin Psychiatry; 2001 Nov; 62(11):860-8. PubMed ID: 11775045
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of pregabalin in the treatment of generalized anxiety disorder: a 6-week, multicenter, randomized, double-blind, placebo-controlled comparison of pregabalin and venlafaxine.
Montgomery SA; Tobias K; Zornberg GL; Kasper S; Pande AC
J Clin Psychiatry; 2006 May; 67(5):771-82. PubMed ID: 16841627
[TBL] [Abstract][Full Text] [Related]
20. Double-blind, fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorder.
Ballenger JC; Wheadon DE; Steiner M; Bushnell W; Gergel IP
Am J Psychiatry; 1998 Jan; 155(1):36-42. PubMed ID: 9433336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
